Carl Salzman

8.0k total citations · 1 hit paper
162 papers, 4.9k citations indexed

About

Carl Salzman is a scholar working on Psychiatry and Mental health, Experimental and Cognitive Psychology and Clinical Psychology. According to data from OpenAlex, Carl Salzman has authored 162 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Psychiatry and Mental health, 33 papers in Experimental and Cognitive Psychology and 29 papers in Clinical Psychology. Recurrent topics in Carl Salzman's work include Schizophrenia research and treatment (43 papers), Treatment of Major Depression (25 papers) and Sleep and related disorders (18 papers). Carl Salzman is often cited by papers focused on Schizophrenia research and treatment (43 papers), Treatment of Major Depression (25 papers) and Sleep and related disorders (18 papers). Carl Salzman collaborates with scholars based in United States, Australia and Brazil. Carl Salzman's co-authors include Richard I. Shader, Jerold S. Harmatz, Barry D. Lebowitz, Edison Miyawaki, Dilip V. Jeste, Sonia Ancoli‐Israel, Liat Ayalon, Lon S. Schneider, Pierre N. Tariot and Daniel E. Casey and has published in prestigious journals such as New England Journal of Medicine, JAMA and American Journal of Psychiatry.

In The Last Decade

Carl Salzman

157 papers receiving 4.5k citations

Hit Papers

Handbook of Psychiatric Measures 2001 2026 2009 2017 2001 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Handbook of Psychiatric Measures
    2001 989 citations Carl Salzman profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl Salzman United States 33 2.3k 1.3k 1.1k 788 591 162 4.9k
John P. Docherty United States 34 2.8k 1.2× 1.8k 1.3× 587 0.6× 596 0.8× 213 0.4× 101 5.1k
Hélène Verdoux France 38 3.8k 1.6× 2.0k 1.5× 1.0k 1.0× 533 0.7× 696 1.2× 176 6.3k
James Lindesay United Kingdom 37 1.5k 0.7× 976 0.7× 741 0.7× 239 0.3× 427 0.7× 112 4.2k
Pierre‐Michel Llorca France 41 3.0k 1.3× 1.7k 1.3× 827 0.8× 854 1.1× 567 1.0× 307 6.3k
Antoni Serrano‐Blanco Spain 36 1.4k 0.6× 1.2k 0.9× 689 0.7× 942 1.2× 364 0.6× 130 4.2k
Max L. Stek Netherlands 44 3.1k 1.3× 1.3k 1.0× 564 0.5× 1.1k 1.4× 535 0.9× 217 6.6k
Ira D. Glick United States 39 3.5k 1.5× 2.0k 1.5× 378 0.4× 598 0.8× 321 0.5× 205 5.4k
D. W. K. Kay United Kingdom 38 2.2k 0.9× 1.0k 0.8× 302 0.3× 378 0.5× 379 0.6× 109 4.4k
Michael J. Helms United States 40 1.7k 0.7× 799 0.6× 462 0.4× 925 1.2× 597 1.0× 78 6.8k
Joanna Moncrieff United Kingdom 38 2.0k 0.9× 1.4k 1.0× 576 0.5× 975 1.2× 686 1.2× 157 4.8k

Countries citing papers authored by Carl Salzman

Since Specialization
Citations

This map shows the geographic impact of Carl Salzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Salzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Salzman more than expected).

Fields of papers citing papers by Carl Salzman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Salzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Salzman. The network helps show where Carl Salzman may publish in the future.

Co-authorship network of co-authors of Carl Salzman

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Salzman. A scholar is included among the top collaborators of Carl Salzman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Salzman. Carl Salzman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keshavan, Matcheri S., Seo Ho Song, & Carl Salzman. (2025). Neuroscience in Pictures: 4. Depression. Asian Journal of Psychiatry. 107. 104448–104448. 1 indexed citations
2.
Silberman, Edward, Antônio Egídio Nardi, Vladan Starčević, et al.. (2023). Resolving the Paradox of Long-Term Benzodiazepine Treatment. The Journal of Clinical Psychiatry. 84(6). 3 indexed citations
3.
Silberman, Edward, Richard Balon, Vladan Starčević, et al.. (2020). Benzodiazepines: it's time to return to the evidence. The British Journal of Psychiatry. 218(3). 125–127. 31 indexed citations
4.
Salzman, Carl. (2018). Treat the Patient, Not the Rule Book…. The Journal of Nervous and Mental Disease. 206(5). 380–382.
5.
Salzman, Carl. (2013). Management Considerations for Late-Life Depression. 2. 0–0.
6.
Montgomery, Stuart, Aartjan T.F. Beekman, Joel Sadavoy, et al.. (2013). Consensus Statement on Depression in the Elderly. 2. 0–0.
7.
Salzman, Carl, Dilip V. Jeste, Roger E. Meyer, et al.. (2008). Elderly Patients With Dementia-Related Symptoms of Severe Agitation and Aggression. The Journal of Clinical Psychiatry. 69(6). 889–898. 167 indexed citations
8.
Zisook, Sidney, Ira D. Glick, James W. Jefferson, et al.. (2008). Teaching Psychopharmacology. Journal of Clinical Psychopharmacology. 28(1). 96–100. 11 indexed citations
9.
Pearson, Sallie‐Anne, Stephen B. Soumerai, Connie Mah, et al.. (2006). Racial Disparities in Access After Regulatory Surveillance of Benzodiazepines. Archives of Internal Medicine. 166(5). 572–572. 29 indexed citations
10.
Weiden, Peter J., Penelope Hopwood, A. George Awad, et al.. (2001). An Innovative Approach to Clinical Communication in Schizophrenia: The Approaches to Schizophrenia Communication Checklists. CNS Spectrums. 6(4). 333–338. 30 indexed citations
11.
Pace‐Schott, Edward F., et al.. (2001). SSRI Treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects. Journal of Sleep Research. 10(2). 129–142. 38 indexed citations
12.
Yeung, Paul, Pierre N. Tariot, Lon S. Schneider, Carl Salzman, & Ihor W Rak. (2000). Quetiapine for Elderly Patients With Psychotic Disorders. Psychiatric Annals. 30(3). 197–201. 19 indexed citations
13.
Salzman, Carl. (1997). The Benzodiazepine Controversy: Therapeutic Effects versus Dependence, Withdrawal, and Toxicity. Harvard Review of Psychiatry. 4(5). 279–282. 15 indexed citations
14.
Salzman, Carl, et al.. (1993). Neurobiologic Basis of Anxiety and Its Treatment. Harvard Review of Psychiatry. 1(4). 197–206. 26 indexed citations
15.
Salzman, Carl. (1993). Benzodiazepine treatment of panic and agoraphobic symptoms: Use, dependence, toxicity, abuse. Journal of Psychiatric Research. 27. 97–110. 31 indexed citations
16.
Watsky, Eric & Carl Salzman. (1991). Psychotropic Drug Interactions. Psychiatric Services. 42(3). 247–256. 10 indexed citations
17.
Salzman, Carl. (1990). Mandatory Monitoring for Side Effects. New England Journal of Medicine. 323(12). 827–829. 5 indexed citations
18.
Solomon, David A., Edison Miyawaki, & Carl Salzman. (1990). Benzodiazepine augmentation of the treatment of disruptive psychotic behavior. Birkhäuser Basel eBooks. 35. 139–149. 1 indexed citations
19.
Salzman, Carl, et al.. (1990). Clozapine: Benefits and Risks. Psychiatric Services. 41(4). 379–380. 11 indexed citations
20.
DiMascio, Alberto, et al.. (1967). An evaluation of isoquinazepon (SAH-1123).. PubMed. 9(10). 517–21. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John P. Docherty Breakdown of academic impact, for papers by Hélène Verdoux Breakdown of academic impact, for papers by James Lindesay Breakdown of academic impact, for papers by Pierre‐Michel Llorca Breakdown of academic impact, for papers by Antoni Serrano‐Blanco Breakdown of academic impact, for papers by Max L. Stek Breakdown of academic impact, for papers by Ira D. Glick Breakdown of academic impact, for papers by D. W. K. Kay Breakdown of academic impact, for papers by Michael J. Helms Breakdown of academic impact, for papers by Joanna Moncrieff
Rankless by CCL
2026